Literature DB >> 9715332

Premorbid adjustment and personality in people with schizophrenia.

A Malmberg1, G Lewis, A David, P Allebeck.   

Abstract

BACKGROUND: Schizoid personality and poor social adjustment have been thought of as common antecedents of schizophrenia but the existing literature is inconclusive. We have carried out a large cohort study with improved methodology.
METHOD: The premorbid personality and adjustment of 50,054 Swedish men were assessed on entry into the army at the age of 18. Individuals who developed schizophrenia or another psychosis after 15-year follow-up were identified. Odds ratios for variables independently associated with the later development of schizophrenia were calculated, adjusting for potential confounders.
RESULTS: Four variables reflecting early problems with interpersonal relationships were strongly associated with later schizophrenia and, to a lesser extent, non-schizophrenic psychoses, but also occurred commonly in the cohort as a whole. These associations with schizophrenia persisted after early-onset cases were excluded, though their predictive value was low (3.0%, 95% CI 1.5-4.5).
CONCLUSIONS: Some aspects of premorbid personality and adjustment may act as risk factors for schizophrenia. The results appear to be most consistent with a multi-factorial aetiology for schizophrenia and offer tentative support for a psychological disturbance mediating genetic and environmental effects on the causal pathway to the illness.

Entities:  

Mesh:

Year:  1998        PMID: 9715332     DOI: 10.1192/bjp.172.4.308

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  35 in total

1.  Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study.

Authors:  Stanley Zammit; Peter Allebeck; Sven Andreasson; Ingvar Lundberg; Glyn Lewis
Journal:  BMJ       Date:  2002-11-23

Review 2.  Approaches for adolescents with an affected family member with schizophrenia.

Authors:  Vaibhav A Diwadkar; Konasale M Prasad; Matcheri S Keshavan
Journal:  Curr Psychiatry Rep       Date:  2004-08       Impact factor: 5.285

3.  Premorbid personality and insight in first-episode psychosis.

Authors:  Maria S Campos; Elena Garcia-Jalon; James K Gilleen; Anthony S David; Victor M D Peralta; Manuel J Cuesta
Journal:  Schizophr Bull       Date:  2010-10-25       Impact factor: 9.306

4.  Early risk factors for criminal offending in schizophrenia: a 35-year longitudinal cohort study.

Authors:  Asa Eriksson; Anders Romelsjö; Marlene Stenbacka; Anders Tengström
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-07-04       Impact factor: 4.328

5.  Dis-sociality: the phenomenological approach to social dysfunction in schizophrenia.

Authors:  Giovanni Stanghellini; Massimo Ballerini
Journal:  World Psychiatry       Date:  2002-06       Impact factor: 49.548

Review 6.  Epidemiology of schizophrenia: review of findings and myths.

Authors:  Erick L Messias; Chuan-Yu Chen; William W Eaton
Journal:  Psychiatr Clin North Am       Date:  2007-09

7.  Predictors of psychosis: a 50-year follow-up of the Lundby population.

Authors:  Mats Bogren; Cecilia Mattisson; Kristian Tambs; Vibeke Horstmann; Povl Munk-Jørgensen; Per Nettelbladt
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-05-29       Impact factor: 5.270

Review 8.  Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

9.  Family history of psychosis as a predictor or protective factor of social maladjustment in a population at clinical high risk for psychosis.

Authors:  S Lucy Poe; Kelly E Gill; Gary Brucato; Cheryl M Corcoran; Ragy R Girgis
Journal:  Psychiatry Res       Date:  2014-07-14       Impact factor: 3.222

10.  Childhood determinants of adult psychiatric disorder.

Authors:  Tom Fryers; Traolach Brugha
Journal:  Clin Pract Epidemiol Ment Health       Date:  2013-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.